• 10 Hits
  • Search Condition : Filter (MeSH = Doxorubicin / therapeutic use)
Species Resource Title
Human and Animal Cells THP-1 Tumor microenvironment-regulated nanoplatforms for the inhibition of tumor growth and metastasis in chemo-immunotherapy.
Human and Animal Cells A549 Elevation of Anticancer Drug Toxicity by Caffeine in Spheroid Model of Human Lung Adenocarcinoma A549 Cells Mediated by Reduction in Claudin-2 and Nrf2 Expression.
Human and Animal Cells LNCap.FGC(RCB2144) KCa1.1 K+ Channel Inhibition Overcomes Resistance to Antiandrogens and Doxorubicin in a Human Prostate Cancer LNCaP Spheroid Model.
Human and Animal Cells MCF7(RCB1904) Identification of carbonyl reductase 1 as a resveratrol-binding protein by affinity chromatography using 4'-amino-3,5-dihydroxy-trans-stilbene.
Human and Animal Cells MDA-MB-453(RCB1192) Luteolin attenuates doxorubicin-induced cytotoxicity to MCF-7 human breast cancer cells.
Human and Animal Cells SLVL(RCB1702) Combination lenalidomide-rituximab immunotherapy activates anti-tumour immunity and induces tumour cell death by complementary mechanisms of action in follicular lymphoma.
Human and Animal Cells Size-controlled, dual-ligand modified liposomes that target the tumor vasculature show promise for use in drug-resistant cancer therapy.
Human and Animal Cells HeLa(RCB0007) Accumulation of arginine-rich cell-penetrating peptides in tumors and the potential for anticancer drug delivery in vivo.
Human and Animal Cells Hep G2 Doxorubicin-conjugated anti-midkine monoclonal antibody as a potential anti-tumor drug.
Human and Animal Cells V79(RCB0008) Thermal enhancement of pirarubicin (THP-adriamycin) by mild hyperthermia in vitro.